Icon completes Verisome PhIII; Indian scientists make cancer nanoparticles;

> Icon Bioscience reported that its Verisome delivery platform for post-cataract surgery inflammation has completed a Phase III study. Release

> A team at the Indian Institute of Science has developed nanocapsules to deliver cancer drugs. More